
FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease
For Immediate Release: May 16, 2025 The U.S. Food and Drug Administration today cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer’s disease. The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is …